Infection with human papillomavirus and HIV among young women in Kampala, Uganda

Journal of Infectious Diseases

Volumn 197, Issue 4, 2008, Pages 555-562

  Banura, Cecily ^a,c   Franceschi, Silvia ^d   Van Doorn, Leen Jan ^e   Arslan, Annie ^d   Wabwire Mangen, Fred ^a   Mbidde, Edward K ^b   Quint, Wim ^e   Weiderpass, Elisabete ^c,f,g  

^a MAKERERE UNIVERSITY   (Uganda)

^b Virus Research Institute   (Uganda)

^c KAROLINSKA INSTITUTE   (Sweden)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e DDL DIAGNOSTIC LABORATORY   (Netherlands)

^f CANCER REGISTRY OF NORWAY   (Norway)

^g FOLKHÄLSAN RESEARCH CENTER   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DISEASE ASSOCIATION; EMPLOYMENT; FEMALE; GROUPS BY AGE; HEALTH SERVICE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEXUAL BEHAVIOR; SEXUALITY; UGANDA; UTERINE CERVICITIS; UTERINE CERVIX CANCER; VIRUS STRAIN; WART VIRUS;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; ALPHAPAPILLOMAVIRUS; CARRIER STATE; CHILD; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UGANDA; UTERINE CERVICAL DISEASES;

EID: 38949104600     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/526792     Document Type: Article

References (34)

1. Parkin DM, Ferlay J, Hamdi-Cherif M, et al. Cancer in Africa: epidemiology and prevention. Lyon: IARC Press, 2003.
2. Clifford GM, Gonçalves MA, Franceschi S, HPV and HIV Study Group. Human papillomavirus types among women infected with HIV: a metaanalysis. AIDS 2006; 20:2337- 44.
3. Palefsky JM, Holly EA. Chapter 6: Immunosuppression and coinfection with HIV. J Natl Cancer Inst Monogr 2003; 41-6.
4. Moscicki AB, Ellenberg JH, Vermund SH, et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 2000; 154:127-34.
5. PATH. Cervical cancer vaccine. Available at: http://www.path.org/ projects/cervical_cancer_vaccine.php. Accessed on 19 December 2007.
6. Serwadda D, Wawer MJ, Shah KV, et al. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. J Infect Dis 1999; 180:1316 -9.
7. Sankaranarayanan R, Basu P, Wesley RS, et al. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer 2004; 110:907-13.
8. Sellors JW, Sankaranarayanan R. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginner's manual. Lyon: International Agency for Research on Cancer, 2003.
9. Kleter B, van Doorn LJ, ter Schegget J, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998; 153:1731-9.
10. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37:2508 -17.
11. Muñoz N, Bosch FX, Castellsagué X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111:278-85.
12. Downing RG, Otten RA, Marum E, et al. Optimizing the delivery of HIV counseling and testing services: the Uganda experience using rapid HIV antibody test algorithms. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:384-8.
13. Molano M, van den Brule AJ, Plummer M, et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol 2003; 158:486-94.
14. Thomas JO, Herrero R, Omigbodun AA, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004; 90:638-45.
15. Clifford GM, Franceschi S. HPV in sub-Saharan Africa. Papillomavirus Report 2005; 16:322- 6.
16. Castellsagué X, Menendez C, Loscertales MP, et al. Human papillomavirus genotypes in rural Mozambique. Lancet 2001; 358:1429 -30.
17. Mayaud P, Gill DK, Weiss HA, et al. The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Sex Transm Infect 2001; 77:248 -54.
18. De Vuyst H, Steyaert S, Van Renterghem L, et al. Distribution of human papillomavirus in a family planning population in Nairobi, Kenya. Sex Transm Dis 2003; 30:137- 42.
19. Baay MF, Kjetland EF, Ndhlovu PD, et al. Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution. J Med Virol 2004; 73:481-5.
20. Iftner T, Villa LL. Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 2003; 80-8.
21. Burchell AN, Richardson H, Mahmud SM, et al. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 2006; 163:534-43.
22. Kitchener HC, Almonte M, Wheeler P, et al. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer 2006; 95:56-61.
23. Molano M, Posso H, Weiderpass E, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002; 87:324 -33.
24. Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357:1831- 6.
25. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157:218-26.
26. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002; 29:725-35.
27. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366:991- 8.
28. de Sanjosé S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical HPV DNA in 157,897 women with normal cytology: a meta-analysis of 78 studies. Lancet Infect Dis 2007; 7:453-9.
29. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356:1928-43.
30. Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007; 369:2161-70.
31. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007; 57:7-28.
32. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study. J Infect Dis 2002; 186:462-9.
33. Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005; 337:76-84.
34. Dillner J, Arbyn M, Dillner L. Translational mini-review series on vaccines: monitoring of human papillomavirus vaccination. Clin Exp Immunol 2007; 148:199 -207.